Rituximab for rheumatoid arthritis-related interstitial lung disease: A systematic review and meta-analysis
{{output}}
Objectives: This systematic review and meta-analysis aimed at summarizing the evidence of efficacy and safety of rituximab in rheumatoid arthritis-related interstitial lung disease (RA-ILD). ... ...
